| BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design W Farnaby, M Koegl, MJ Roy, C Whitworth, E Diers, N Trainor, D Zollman, ... Nature chemical biology 15 (7), 672-680, 2019 | 392 | 2019 |
| Drugging an undruggable pocket on KRAS D Kessler, M Gmachl, A Mantoulidis, LJ Martin, A Zoephel, M Mayer, ... Proceedings of the National Academy of Sciences 116 (32), 15823-15829, 2019 | 349 | 2019 |
| BI-3406, a potent and selective SOS1–KRAS interaction inhibitor, is effective in KRAS-driven cancers through combined MEK inhibition MH Hofmann, M Gmachl, J Ramharter, F Savarese, D Gerlach, ... Cancer Discovery 11 (1), 142-157, 2021 | 283 | 2021 |
| Structure-based design of an in vivo active selective BRD9 inhibitor LJ Martin, M Koegl, G Bader, XL Cockcroft, O Fedorov, D Fiegen, ... Journal of medicinal chemistry 59 (10), 4462-4475, 2016 | 206 | 2016 |
| Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition AF Hohmann, LJ Martin, JL Minder, JS Roe, J Shi, S Steurer, G Bader, ... Nature chemical biology 12 (9), 672-679, 2016 | 161 | 2016 |
| Chemically induced degradation of the oncogenic transcription factor BCL6 N Kerres, S Steurer, S Schlager, G Bader, H Berger, M Caligiuri, C Dank, ... Cell reports 20 (12), 2860-2875, 2017 | 157 | 2017 |
| Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza SJF Macdonald, R Cameron, DA Demaine, RJ Fenton, G Foster, D Gower, ... Journal of medicinal chemistry 48 (8), 2964-2971, 2005 | 128 | 2005 |
| Highly selective PTK2 proteolysis targeting chimeras to probe focal adhesion kinase scaffolding functions J Popow, H Arnhof, G Bader, H Berger, A Ciulli, D Covini, C Dank, ... Journal of Medicinal Chemistry 62 (5), 2508-2520, 2019 | 118 | 2019 |
| Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen SJF Macdonald, KG Watson, R Cameron, DK Chalmers, DA Demaine, ... Antimicrobial agents and chemotherapy 48 (12), 4542-4549, 2004 | 117 | 2004 |
| Discovery of Novel Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one Compounds as Chemically Stable and Orally Active Inhibitors of the MDM2–p53 Interaction A Gollner, D Rudolph, H Arnhof, M Bauer, SM Blake, G Boehmelt, ... Journal of medicinal chemistry 59 (22), 10147-10162, 2016 | 108 | 2016 |
| Start selective and rigidify: the discovery path toward a next generation of EGFR tyrosine kinase inhibitors H Engelhardt, D Böse, M Petronczki, D Scharn, G Bader, A Baum, ... Journal of medicinal chemistry 62 (22), 10272-10293, 2019 | 104 | 2019 |
| 2-Ethoxybenzoxazole as a bioisosteric replacement of an ethyl benzoate group in a human rhinovirus (HRV) capsid binder RN Brown, R Cameron, DK Chalmers, S Hamilton, A Luttick, GY Krippner, ... Bioorganic & medicinal chemistry letters 15 (8), 2051-2055, 2005 | 86 | 2005 |
| Pan-KRAS inhibitor disables oncogenic signalling and tumour growth D Kim, L Herdeis, D Rudolph, Y Zhao, J Böttcher, A Vides, ... Nature 619 (7968), 160-166, 2023 | 85 | 2023 |
| Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase KG Watson, R Cameron, RJ Fenton, D Gower, S Hamilton, B Jin, ... Bioorganic & medicinal chemistry letters 14 (6), 1589-1592, 2004 | 83 | 2004 |
| Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3 J Böttcher, D Dilworth, U Reiser, RA Neumüller, M Schleicher, ... Nature chemical biology 15 (8), 822-829, 2019 | 74 | 2019 |
| Microwave-assisted parallel synthesis of fused heterocycles in a novel parallel multimode reactor M Treu, T Karner, R Kousek, H Berger, M Mayer, DB McConnell, A Stadler Journal of Combinatorial Chemistry 10 (6), 863-868, 2008 | 72 | 2008 |
| An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirus KG Watson, RN Brown, R Cameron, DK Chalmers, S Hamilton, B Jin, ... Journal of medicinal chemistry 46 (15), 3181-3184, 2003 | 66 | 2003 |
| Targeting son of sevenless 1: the pacemaker of KRAS D Kessler, D Gerlach, N Kraut, DB McConnell Current Opinion in Chemical Biology 62, 109-118, 2021 | 61 | 2021 |
| Intracellular Trapping of the Selective Phosphoglycerate Dehydrogenase (PHGDH) Inhibitor BI-4924 Disrupts Serine Biosynthesis H Weinstabl, M Treu, J Rinnenthal, SK Zahn, P Ettmayer, G Bader, ... Journal of Medicinal Chemistry 62 (17), 7976-7997, 2019 | 49 | 2019 |
| Drugging all RAS isoforms with one pocket D Kessler, A Bergner, J Böttcher, G Fischer, S Döbel, M Hinkel, ... Future medicinal chemistry 12 (21), 1911-1923, 2020 | 48 | 2020 |
